Virtus Biotech Clinical Trials ETF

BBCAMEX · USD
45.15USD0.00 (-1.39%)

Virtus Biotech Clinical Trials ETF (BBC) Covered Calls

As of September 25, 2026, BBC has 31 covered call opportunities in the coming three months. Return ranges from 4.0 to 24.1% until expiration. Annualized return ranges from 15.7 to 157.4%. The nearest expiration is October 16, 2026. Maximum potential profit is $1,090.

Read more

Running BBC covered calls helps you generate consistent income from Virtus Biotech Clinical Trials ETF's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Virtus Biotech Clinical Trials ETF involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best BBC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if BBC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling BBC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Virtus Biotech Clinical Trials ETF covered call is worth writing.

The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.

Income-focused investors, long-term BBC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling BBC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Virtus Biotech Clinical Trials ETF covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryExchange Traded Fund
  • SectorFinancial
  • IV percentile54.76% Neutral
  • Market cap (M$)—
  • 52 weeks high-19.63%
  • 52 weeks low74.53%
  • Analyst recommendation—
  • Target price—
  • Dividend—
  • Payout ratio—
  • Earnings date—
  • P/E—
  • Future P/E—
  • EPS (ttm)—
  • EPS growth next 5 years—

As of September 25, 2026

2026-11-205656.0024.030.051.451090.0024.14157.35-0.11+0.1701.40
2026-10-162148.006.310.501.65335.007.42128.96-1.11+0.3301.15
2026-11-205654.0019.600.051.60890.0019.71128.48-0.11+0.2001.55
2026-11-205653.0017.390.051.70790.0017.50114.04-0.11+0.2101.65
2026-11-205652.0015.170.301.90715.0015.84103.22-0.66+0.2501.60
2026-11-205651.0012.960.502.10635.0014.0691.67-1.11+0.2901.60
2026-10-162147.004.100.451.90230.005.0988.54-1.00+0.3801.45
2026-11-205650.0010.740.352.30520.0011.5275.07-0.78+0.3101.95
2026-10-162146.001.880.952.25180.003.9969.29-2.10+0.4611.30
2026-11-205649.008.530.252.55410.009.0859.19-0.55+0.3422.30

As of September 25, 2026

Sell covered calls with the data behind you

Find the best BBC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial